<DOC>
	<DOCNO>NCT00004802</DOCNO>
	<brief_summary>OBJECTIVES : I. Assess efficacy dichlorphenamide treatment episodic weakness attack patient hyperkalemic periodic paralysis , paramyotonia congenita periodic paralysis , hypokalemic periodic paralysis .</brief_summary>
	<brief_title>Phase III Randomized , Double-Blind , Placebo-Controlled Study Dichlorphenamide Periodic Paralyses Associated Sodium Channel Disorders</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double-blind study . Patients stratify participate institution diagnosis . The weekly attack rate determine 8-week assessment prior therapy initiation crossover . Patients randomly assign oral dichlorphenamide ( DCP ) placebo 9 week cross alternate treatment . Patients DCP baseline continue dose ; acetazolamide ( ACZ ) baseline receive DCP dose equivalent one fifth ACZ dose .</detailed_description>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Myotonic Disorders</mesh_term>
	<mesh_term>Hypokalemic Periodic Paralysis</mesh_term>
	<mesh_term>Paralysis , Hyperkalemic Periodic</mesh_term>
	<mesh_term>Dichlorphenamide</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Hypokalemic periodic paralysis Typical clinical profile Normal serum thyroxine Hypokalemia spontaneous glucoseinduced paralytic attack subject affect family member Periodic paralysis associate sodium channel 17q alphasubunit , e.g . : Hyperkalemic periodic paralysis without myotonia Paramyotonia congenita periodic paralysis Distinct , regular episode weakness least week 3 time day No history worsen symptom carbonic anhydrase inhibitor No history lifethreatening weakness episode prior treatment No atypical periodic paralysis without demonstrable 17q alphasubunit defect Prior/Concurrent Therapy No requirement follow agent , unless periodic paralysis : Diuretics Antiepileptics Antiarrhythmics Magnesium supplement Steroids Calcium supplement Betablockers Potassium supplement Calcium channel blocker Patient Characteristics Hepatic : No hepatic disease Renal : No renal failure No nephrolithiasis Cardiovascular : No heart disease No cardiac arrhythmia Pulmonary : No restrictive obstructive lung disease Other : No active thyroid disease No pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 1998</verification_date>
	<keyword>neurologic psychiatric disorder</keyword>
	<keyword>periodic paralysis</keyword>
	<keyword>rare disease</keyword>
</DOC>